Literature DB >> 9518018

Indinavir-associated hepatitis in patients with advanced HIV infection.

E Vergis1, D L Paterson, N Singh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9518018     DOI： 10.1258/0956462981920883

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN： 0956-4624            Impact factor:   1.359


× No keyword cloud information.
  3 in total

1.  Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group.

Authors:  M Savès; F Raffi; P Clevenbergh; B Marchou; A Waldner-Combernoux; P Morlat; V Le Moing; C Rivière; G Chêne; C Leport
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

Review 2.  Hepatotoxicity by Drugs: The Most Common Implicated Agents.

Authors:  Einar S Björnsson
Journal:  Int J Mol Sci       Date:  2016-02-06       Impact factor: 5.923

Review 3.  Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale?

Authors:  Athanasios-Dimitrios Bakasis; Theodoros Androutsakos
Journal:  Cells       Date:  2021-05-15       Impact factor: 6.600
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.